Streetbeat News

Stock Prices

LLY

NVO

Novo Nordisk CEO Lars Fruergaard Jorgensen expressed optimism about the prolonged patient adherence to the obesity drug Wegovy at the JPMorgan Healthcare conference. He cited data showing a 40% adherence rate after a year, surpassing older medications. Novo Nordisk and Eli Lilly are leaders in the weight loss drug market, which could be worth $100 billion by 2030. Jorgensen welcomed competition and mentioned the approval of Eli Lilly's Zepbound. Novo Nordisk is also exploring oral treatments, with a once-daily weight-loss pill showing promise in trials. NVO shares saw a slight increase in premarket trading.

Portfolio Pulse from Vandana Singh

January 10, 2024 | 11:43 am

DTC

Jefferies analyst Randal Konik downgraded Solo Brands (NYSE:DTC) from Buy to Hold and reduced the price target from $12 to $4, indicating a more cautious outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 11:40 am

WWD

Goldman Sachs analyst Noah Poponak has upgraded Woodward (NASDAQ:WWD) from Sell to Buy and increased the price target from $105 to $153.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 11:36 am

CRERF

LVMUY

SNY

Sanofi SA (NASDAQ:SNY) is sponsoring the 2024 Olympic Games in Paris to transform its image and attract a younger workforce. The company is joining other French companies like LVMH and Carrefour in this endeavor. Sanofi's commitment includes backing athletes and involving over 8,000 employees in the Games. The financial investment is speculated to be a significant sum, though exact figures are not disclosed. The impact on investor sentiment is uncertain given Sanofi's recent financial challenges and business model changes. SNY shares closed at $51.76 on Tuesday.

Portfolio Pulse from Vandana Singh

January 10, 2024 | 11:36 am

FBRT

JMP Securities analyst Steven Delaney has upgraded Franklin BSP Realty Trust (FBRT) from Market Perform to Market Outperform and set a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 11:33 am

SGH

Needham analyst Quinn Bolton has reaffirmed a Buy rating on SMART Global Holdings (NASDAQ:SGH) and increased the price target from $22 to $24.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 11:31 am

BE

Baird analyst Ben Kallo has upgraded Bloom Energy (NYSE:BE) from Neutral to Outperform and increased the price target from $16 to $22, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 11:30 am

RJF

JP Morgan analyst Michael Cho upgraded Raymond James Financial (NYSE:RJF) from Neutral to Overweight and increased the price target from $110 to $135, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 11:28 am

CPK

RBC Capital analyst Shelby Tucker has upgraded Chesapeake Utilities (NYSE:CPK) from Sector Perform to Outperform and increased the price target from $111 to $123.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 11:27 am

DUK

RBC Capital analyst Shelby Tucker has upgraded Duke Energy (NYSE:DUK) from Sector Perform to Outperform and increased the price target from $101 to $113.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 11:26 am